Why did Edgewise's operating expenses surge in Q4 2024?
5/8/2025 06:29pm
Aime
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) did not experience a surge in operating expenses in Q4 2024. In fact, the company's operating expenses were well-managed, and no significant increases were reported12.
Source:
1.
EWTX Latest Report Period
more
less
Explore
Screener
What are the best stocks to buy now?
Analysis
Are KRP dividends of 0.47 per share well covered by its operating cash flow?
Learn
Advanced technical indicators and how they are calculated and utilized